96 related articles for article (PubMed ID: 11331326)
1. Detection of chromosome abnormalities pre-high-dose treatment in patients developing therapy-related myelodysplasia and secondary acute myelogenous leukemia after treatment for non-Hodgkin's lymphoma.
Lillington DM; Micallef IN; Carpenter E; Neat MJ; Amess JA; Matthews J; Foot NJ; Young BD; Lister TA; Rohatiner AZ
J Clin Oncol; 2001 May; 19(9):2472-81. PubMed ID: 11331326
[TBL] [Abstract][Full Text] [Related]
2. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies.
Micallef IN; Lillington DM; Apostolidis J; Amess JA; Neat M; Matthews J; Clark T; Foran JM; Salam A; Lister TA; Rohatiner AZ
J Clin Oncol; 2000 Mar; 18(5):947-55. PubMed ID: 10694543
[TBL] [Abstract][Full Text] [Related]
3. Genetic susceptibility to Hodgkin's disease and secondary neoplasias: FISH analysis reveals patients at high risk of developing secondary neoplasia.
Lillington DM; Micallef IN; Carpenter E; Neat MJ; Amess JA; Matthews J; Foot NJ; Lister TA; Young BD; Rohatiner AZ
Ann Oncol; 2002; 13 Suppl 1():40-3. PubMed ID: 12078901
[TBL] [Abstract][Full Text] [Related]
4. Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients.
Armitage JO; Carbone PP; Connors JM; Levine A; Bennett JM; Kroll S
J Clin Oncol; 2003 Mar; 21(5):897-906. PubMed ID: 12610191
[TBL] [Abstract][Full Text] [Related]
5. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma.
Hosing C; Munsell M; Yazji S; Andersson B; Couriel D; de Lima M; Donato M; Gajewski J; Giralt S; Körbling M; Martin T; Ueno NT; Champlin RE; Khouri IF
Ann Oncol; 2002 Mar; 13(3):450-9. PubMed ID: 11996478
[TBL] [Abstract][Full Text] [Related]
6. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
[TBL] [Abstract][Full Text] [Related]
7. Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.
Del Cañizo Mf; Amigo Mf; Hernández JM; Sanz G; Núñez R; Carreras E; Alegre A; Cuesta B; Mataix R
Haematologica; 2000 Apr; 85(4):403-9. PubMed ID: 10756367
[TBL] [Abstract][Full Text] [Related]
8. Secondary myelodysplastic syndrome and acute myelogenous leukemia are significant complications following autologous stem cell transplantation for lymphoma.
Howe R; Micallef IN; Inwards DJ; Ansell SM; Dewald GW; Dispenzieri A; Gastineau DA; Gertz MA; Geyer SM; Hanson CA; Lacy MQ; Tefferi A; Litzow MR
Bone Marrow Transplant; 2003 Aug; 32(3):317-24. PubMed ID: 12858205
[TBL] [Abstract][Full Text] [Related]
9. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
[TBL] [Abstract][Full Text] [Related]
10. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma.
Traweek ST; Slovak ML; Nademanee AP; Brynes RK; Niland JC; Forman SJ
Blood; 1994 Aug; 84(3):957-63. PubMed ID: 8043877
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
Ong DM; Farrugia H; Wei A
Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Granfeldt Østgård LS; Medeiros BC; Sengeløv H; Nørgaard M; Andersen MK; Dufva IH; Friis LS; Kjeldsen E; Marcher CW; Preiss B; Severinsen M; Nørgaard JM
J Clin Oncol; 2015 Nov; 33(31):3641-9. PubMed ID: 26304885
[TBL] [Abstract][Full Text] [Related]
13. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
Bennett JM; Kaminski MS; Leonard JP; Vose JM; Zelenetz AD; Knox SJ; Horning S; Press OW; Radford JA; Kroll SM; Capizzi RL
Blood; 2005 Jun; 105(12):4576-82. PubMed ID: 15731177
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
15. Secondary myelodysplastic syndromes and leukemias.
Giles FJ; Koeffler HP
Curr Opin Hematol; 1994 Jul; 1(4):256-60. PubMed ID: 9371291
[TBL] [Abstract][Full Text] [Related]
16. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer.
Nichols G; de Castro K; Wei LX; Griffin M; Lin N; Oratzi A; Murty VV; Troxel A; Vahdat L; Hesdorffer C
Leukemia; 2002 Sep; 16(9):1673-9. PubMed ID: 12200680
[TBL] [Abstract][Full Text] [Related]
17. Therapy-related myelodysplasia and/or acute myeloid leukaemia after autologous haematopoietic progenitor cell transplantation in a prospective single centre cohort of 221 patients.
Beauchamp-Nicoud A; Feneux D; Bayle C; Bernheim A; Léonard C; Koscielny S; Tchernia G; Bourhis JH
Br J Haematol; 2003 Jul; 122(1):109-17. PubMed ID: 12823352
[TBL] [Abstract][Full Text] [Related]
18. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.
Roboz GJ; Bennett JM; Coleman M; Ritchie EK; Furman RR; Rossi A; Jhaveri K; Feldman EJ; Leonard JP
Leuk Res; 2007 Aug; 31(8):1141-4. PubMed ID: 17475326
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal aberrations characteristic for sAML/sMDS are not detectable by random screening using FISH in peripheral blood-derived grafts used for autologous transplantation.
Weber MH; Wenzel U; Thiel E; Knauf WU
J Hematother Stem Cell Res; 2000 Dec; 9(6):861-5. PubMed ID: 11177598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]